Treace Medical Concepts, Inc. (TMCI)
4.28
+0.01
(+0.23%)
USD |
NASDAQ |
Nov 03, 16:00
4.27
-0.01
(-0.23%)
After-Hours: 20:00
Treace Medical Concepts Enterprise Value : 306.64M for Nov. 3, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 03, 2026 | 306.64M |
| November 02, 2026 | 305.99M |
| October 30, 2026 | 316.43M |
| October 29, 2026 | 357.53M |
| October 28, 2026 | 342.52M |
| October 27, 2026 | 324.26M |
| October 26, 2026 | 315.78M |
| October 23, 2026 | 305.99M |
| October 22, 2026 | 306.64M |
| October 21, 2026 | 297.51M |
| October 20, 2026 | 292.94M |
| October 19, 2026 | 280.55M |
| October 16, 2026 | 279.90M |
| October 15, 2026 | 296.20M |
| October 14, 2026 | 290.99M |
| October 13, 2026 | 294.90M |
| October 12, 2026 | 294.90M |
| October 09, 2026 | 285.11M |
| October 08, 2026 | 280.22M |
| October 07, 2026 | 281.20M |
| October 06, 2026 | 288.38M |
| October 05, 2026 | 319.69M |
| October 02, 2026 | 313.82M |
| October 01, 2026 | 309.90M |
| September 30, 2026 | 317.08M |
| Date | Value |
|---|---|
| September 29, 2026 | 328.82M |
| September 28, 2026 | 319.69M |
| September 25, 2026 | 320.99M |
| September 24, 2026 | 323.60M |
| September 23, 2026 | 321.65M |
| September 22, 2026 | 326.87M |
| September 21, 2026 | 319.69M |
| September 18, 2026 | 320.34M |
| September 17, 2026 | 322.95M |
| September 16, 2026 | 324.91M |
| September 15, 2026 | 326.21M |
| September 14, 2026 | 329.48M |
| September 11, 2026 | 321.65M |
| September 10, 2026 | 311.21M |
| September 09, 2026 | 322.95M |
| September 08, 2026 | 329.48M |
| September 04, 2026 | 341.22M |
| September 03, 2026 | 345.78M |
| September 02, 2026 | 334.04M |
| September 01, 2026 | 327.52M |
| August 31, 2026 | 334.04M |
| August 28, 2026 | 330.78M |
| August 27, 2026 | 327.52M |
| August 26, 2026 | 335.35M |
| August 25, 2026 | 341.22M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Tactile Systems Technology, Inc. | 499.40M |
| Abbott Laboratories | 216.96B |
| AngioDynamics, Inc. | 474.40M |
| Alphatec Holdings, Inc. | 1.684B |
| AtriCure, Inc. | 2.979B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -15.87M |
| Revenue (Quarterly) | 45.38M |
| Total Expenses (Quarterly) | 61.25M |
| EPS Diluted (Quarterly) | -0.244 |
| Gross Profit Margin (Quarterly) | 78.47% |
| Profit Margin (Quarterly) | -34.98% |
| Earnings Yield | -21.63% |
| Normalized Earnings Yield | -20.93 |